Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study

被引：0
|
作者：
Pearce, Ian [1 ]
Parikh, Soumil [2 ]
Macfadden, Wayne [2 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[2] Novartis Pharma AG, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2566
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Real-world outcomes of ranibizumab treatment in French patients with visual impairment due to Macular Edema secondary to Retinal Vein Occlusion: 24-month results from the BOREAL-RVO study.
    Glacet-Bernard, Agnes
    Girmens, Jean-Francois
    Kodjikian, Laurent
    Delcourt, Cecile
    Fajnkuchen, Franck
    Creuzot-Garcher, Catherine
    Massin, Pascale
    San Nicolas, Nathalie
    OPHTHALMIC RESEARCH, 2023, 66 (01) : 824 - 834
  • [22] Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Rodriguez-Fernandez, Carmen Antia
    Campo-Gesto, Ana
    Lopez-Lopez, Aida
    Gayoso-Rey, Monica
    PHARMACEUTICALS, 2022, 15 (01)
  • [23] Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
    Hamilton, Robin D.
    Clemens, Andreas
    Minnella, Angelo Maria
    Lai, Timothy Y. Y.
    Dai, Hong
    Sakamoto, Taiji
    Cheung, Chui Ming Gemmy
    Ngah, Nor Fariza
    Dunger-Baldauf, Cornelia
    Holz, Frank G.
    PLOS ONE, 2020, 15 (01):
  • [24] Ranibizumab treatment of retinal vein occlusion
    Johnson, Robert N.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2012, 7 (06) : 509 - 515
  • [25] Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial
    Vader, Maartje J. C.
    Schauwvlieghe, Ann-Sofie M. E.
    Verbraak, Frank D.
    Dijkman, Greetje
    Hooymans, Johanna M. M.
    Los, Leonoor, I
    Zwinderman, Aeilko H.
    Peto, Tunde
    Hoyng, Carel B.
    van Leeuwen, Redmer
    Vingerling, Johannes R.
    de Jong-Hesse, Yvonne
    van Lith-Verhoeven, Janneke J. C.
    Dijkgraaf, Marcel G. W.
    Schlingemann, Reinier O.
    OPHTHALMOLOGY RETINA, 2020, 4 (06): : 576 - 587
  • [26] OUTCOMES AT 1 YEAR WITH RANIBIZUMAB IN TREATMENT-NAIVE PATIENTS WITH NEOVASCULAR AGERELATED MACULAR DEGENERATION (NAMD): REAL-WORLD RESULTS FROM THE LUMINOUS STUDY
    Mitchell, Paul
    Macfadden, Wayne
    Lacey, Sue
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 30 - 30
  • [27] Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Central Retinal Vein Occlusion
    Bhisitkul, Robert B.
    Blotner, Steven
    Steffen, Verena
    Haskova, Zdenka
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [28] One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion
    Wang, Nancy
    Hunt, Adrian
    Nguyen, Vuong
    Shah, Janika
    Fraser-Bell, Samantha
    McAllister, Ian
    Barthelmes, Daniel
    Gillies, Mark
    Squirrell, David
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (09) : 1038 - 1046
  • [29] Assesment of patients treated with ranibizumab for retinal vein occlusion (RVO)
    Karakosta, Efi
    Vachtsevanos, Athanasios
    Choulidou, Melantho
    Vasilopoulou, Antonia-Ioanna
    Kazantzidis, Lazaros
    Tsakpinis, Dimitrios
    Polychronakos, Alexandros
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [30] Anatomical Outcomes of the CRUISE Study of Intravitreal Ranibizumab in Patients With Macular Edema Following Central Retinal Vein Occlusion
    Feiner, L.
    Rubio, R.
    Saro, N. N.
    Li, Z.
    Rundle, A.
    Gray, S.
    Murahashi, W. Yee
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345